UniSuper Management’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.27M Buy
6,189
+1,600
+35% +$317K 0.01% 493
2026
Q2
$859K Buy
4,589
+1,789
+64% +$261K ﹤0.01% 519
2026
Q1
$272K Buy
+2,800
New +$283K ﹤0.01% 635

Other funds holding RVMD

UniSuper Management's RVMD Position: Q3 2026 in Review

UniSuper Management increased its Revolution Medicines (RVMD) stake by 35% in Q3 2026, buying an estimated $317K and bringing the position to 6,189 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #493.

UniSuper Management first reported a position in RVMD in Q1 2026 and has held it in 3 quarters since. 758 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • UniSuper Management held 6,189 shares of Revolution Medicines worth $1.27M as of Q3 2026.
  • UniSuper Management bought 1,600 Revolution Medicines shares in Q3 2026, an estimated $317K.
  • Revolution Medicines made up 0.01% of UniSuper Management's portfolio in Q3 2026, its #493 holding.
  • UniSuper Management first reported a position in Revolution Medicines in Q1 2026 and has held it in 3 quarters since.
  • 758 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on UniSuper Management's 13F filing for Q3 2026, filed 26 Oct 2026.